How big is the Lice Treatment Market?

The Lice Treatment Market size is expected to reach USD 1.10 billion in 2024 and grow at a CAGR of 6.66% to reach USD 1.53 billion by 2029. Read More

What is the current Lice Treatment Market size?

In 2024, the Lice Treatment Market size is expected to reach USD 1.10 billion. Read More

Who are the key players in Lice Treatment Market?

Alliance Pharmaceuticals Ltd., Prestige Consumer Healthcare Inc., GlaxoSmithKline plc, Oystershell Consumer Health, Inc. and Perrigo Company plc are the major companies operating in the Lice Treatment Market. Read More

Which is the fastest growing region in Lice Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Lice Treatment Market?

In 2024, the North America accounts for the largest market share in Lice Treatment Market. Read More

What years does this Lice Treatment Market cover, and what was the market size in 2023?

In 2023, the Lice Treatment Market size was estimated at USD 1.03 billion. The report covers the Lice Treatment Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Lice Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Lice Treatment Market Share

Statistics for the 2023 & 2024 Lice Treatment market share, created by Mordor Intelligence™ Industry Reports. Lice Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Lice Treatment Industry

The lice treatment market is moderately competitive. A few of the crucial approaches followed by players functioning in the market were product advancement, invention, acquisitions, and mergers. Some of the companies which are currently dominating the market are Oystershell Consumer Health (Bayer), Alliance Pharmaceuticals Ltd, Perrigo Company plc (Omega Pharma), Arbor Pharmaceuticals Inc. (Azurity Pharmaceuticals), Prestige Consumer Healthcare Inc., GlaxoSmithKline, Johnson and Johnson Services, Inc., Parapro Pharmaceuticals, and Fleming Medical Ltd among others.